Clinical Trial Update: Broxuridine Plus Surgery in Treating Patients With Stage I or Stage II Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating broxuridine plus surgery for Stage I and Stage II prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Broxuridine (broxuridine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage I Prostate Cancer, Stage IIA Prostate Cancer | Phase 2 | Status: COMPLETED